Sorry!!
Hi Madamswer
“…will enable us to provide a clear timetable to product commercialisation and early revenues"
Do you think it possible that in the world of stem cells that the above statement in fact could be true? That perhaps our perception of timelines are warped because we compare it to very different business models. That maybe our expectations are too high for the business of stem cells? Genuine question!
Cheers
Sorry!! Hi Madamswer “…will enable us to provide a clear...
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.010(1.10%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 90.5¢ | $4.638M | 5.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 152669 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 51069 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |